SCHEMBL6978618

SCHEMBL6978618

Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1NC(=O)c1cccc(CCl)c1

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 16/20 0.65
RAF1 P04049 4/20 0.57
BRAF P15056 4/20 0.57
MAPK13 O15264 1/20 0.55
HSPB1 P04792 1/20 0.55
MAPK12 P53778 1/20 0.55
MAPK11 Q15759 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7838063 0.92 MAPK14 (0.67) MAPK14RAF1BRAF
SCHEMBL7680447 0.91 MAPK14 (0.69) MAPK14RAF1BRAFMAPK13HSPB1
SCHEMBL6969309 0.89 MAPK14 (0.62) MAPK14RAF1BRAF
SCHEMBL7841389 0.88 MAPK14 (0.71) MAPK14RAF1BRAFMAPK13HSPB1
SCHEMBL6968243 0.88 MAPK14 (0.61) MAPK14RAF1BRAF
SCHEMBL7678484 0.88 MAPK14 (0.69) MAPK14RAF1BRAF
SCHEMBL6974560 0.87 MAPK14 (0.60) MAPK14RAF1BRAF
SCHEMBL6488842 0.87 MAPK14 (0.71) MAPK14RAF1BRAF
SCHEMBL7679107 0.86 MAPK14 (0.72) MAPK14RAF1BRAF
SCHEMBL5897801 0.86 MAPK14 (0.79) MAPK14RAF1BRAFMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115707-B1 BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2003-11-12 EP disclosed
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed
EP-1115707-A1 BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS AstraZeneca AB (SE) 2001-07-18 EP disclosed
WO-2000018738-A1 BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2000-04-06 WO disclosed